Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration

Research Site, Vienna

Research Site, Brno

Research Site, Ostrava

Research Site, Pilsen

Research Site, Prague

Research Site, Zlín

Research Site, Dijon

Research Site, Lyon

Research Site, Nantes

Research Site, Paris

University of Bonn, Department of Ophthalmology, Bonn

Research Site, Dresden

Research Site, Freiburg im Breisgau

Research Site, Göttingen

Research Site, Hanover

Research Site, Leipzig

Research Site, Mainz

Research Site, Tübingen

Research Site, Budapest

Research Site, Debrecen

Research Site, Nyíregyháza

Research Site, Pécs

Research Site, Szeged

Research Site, Zalaegerszeg

Research Site, Beersheba

Research Site, Haifa

Research Site, Jerusalem

Research Site, Kfar Saba

Research Site, Petah Tikva

Research Site, Ramat Gan

Research Site, Rehovot

Research Site, Tel Aviv

Research Site, Zrifin

Research Site, Bologna

Research Site, Chieti

Research Site, Milan

Research Site, Pisa

Research Site, Roma

Research Site, Torino

Research Site, Bydgoszcz

Research Site, Lodz

Research Site, Rzeszów

Research Site, Tarnowskie Góry

Research Site, Tarnów

Research Site, Warsaw

Research Site, Kazan'

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Barcelona

Research Site, Valencia

Research Site, Zaragoza

Research Site, Kyiv

Research Site, Odesa

Research Site, Bradford

Research Site, Bristol

Research Site, Camberley

Research Site, London

Research Site, Rugby